...Strategic Analysis of Syngenta Jolly was a young, bright girl, studying her Bachelor of Business Administration. When she came home from college, her mind was occupied by the assignment given to her in her Business Strategy Class. She had to pick up a company of her choice and complete strategic analysis, over a period of three years, consisting of size of the organization, financial performance, operational performance, some tailored measures of performance relating to the organization’s industry, competitor analysis, strategic actions of the organization, and strategic issues faced. She thought that she would figure out what procedure to follow from her prescribed textbook ‘Strategic Management – Theory and Application,’ by Adrian Haberberg & Alison Rieple. After a certain thought, she chose Syngenta – headquartered at Basel, Switzerland. Jolly referred to the textbook and jotted down the procedure as below. Procedure for doing the Strategic Analysis: 1) Evaluate financial performance: Calculate the following quantities and analyze them and find out the trend in the last three years. Overall Sales Overall Profit Profitability ratios such as Return on Equity (ROE), Return on Assets (ROA), and Return on Capital Employed(ROCE). 2) Measure operational performance: Page 1 of 29 Calculate the following quantities; find out the trend and analyze: Operating profit Operating profit as a percentage of sales (profit margin) Sales per employee Operating profit per employee ...
Words: 6884 - Pages: 28
...As Bayer approached its first quarter in April 2010, chief executive officer Dr. Marijin Dekkers explained that “Bayer operating performance was back on track, compared with the crisis year 2009”. Bayer Group had sales of $35.1 billion. Clearly, 2010 was a successful year for Bayer in terms of business expansion and growth. The group examined Bayer financial statements to determine if the picture presented by Dekker is reflected in the financial performance of the firm by examining financial ratios using information from the Income statement and balance sheet. Financial ratios help to identify some of the financial strength and weakness of firms. The ratios give us two ways on making meaningful comparisons of the financial data. First, we examined the ratios across time ( for example, five years) to identify trends and we can compare the firm’s ratio with those of other firms. This financial analysis will allows us to see if Bayer is as good as management claims it to be. Analysis of Financial Ratios Bayer’s sales increased by 12.6% from 2009 to 2010, after dropping 5.3% from 2008 to 2009. However, Bayer’s gross profit margin remained stable, increasing from 47.20% in 2006, 49.50% in 2007, 50.00% in 2008, 51.44% in 2009 and 51.50% in 2010. On the other hand, Bayer net profit margin decreased over the same period, falling from 10.77% in 2008 to 9.64% in 2009 to 7.78% in 2010. The decrease in 2010 is more significant than the previous years, this is caused...
Words: 2714 - Pages: 11
...BAYER AG A Financial Analysis Executive Summary This paper tries to analyse the financial strength of Bayer AG and the other aspects associated with its capital structure and dividend policy. The organisation has been trying to change its financial structure to a management-driven one. This is evident from the reduction in the share capital of the organisation and the rise of debt capital, which it has been using efficiently to reduce its tax burden and control the overall cost of capital of the firm. The organisation has been paying dividends at a higher rate compared to its rivals which shows the sound financial health of the organisation. Contents Introduction 4 Market Risk 4 Bayer’s stock to market risk 4 Capital Structure of Bayer AG 7 Impact of Cost of Capital on Investment Decision 10 Dividend payout policy of Bayer 11 Conclusion 14 References 15 Appendices 17 Introduction Bayer AG is a pharmaceutical organisation which was founded in Germany in the year 1863 and is famous for its Aspirin brand. The group consists of almost 350 companies on all continents employing a workforce of approximately 120,000. The activities of the Group are segregated into four business segments. It is trying to transform its organisational structure into a management holding firm. By using this technique, the organisation is attempting to achieve a more dynamic and a flexible structure (Bayer, 2002). ...
Words: 4253 - Pages: 18
...Product Team Cialis (Validus): Getting Ready to Market Christopher Cashen – 5545586 Date: Monday 18th January 2010 MG511 Strategic Marketing Management Assignment Submission Student Name: Christopher Brendan Cashen – 55455863 MMK1 - MBS in Marketing Cialis (Validus) Case Study Programme: Project Title: Module code: MG511 Lecturer: Project Due Date: Ms. Joanne Lynch 18-Jan-2010 Declaration I the undersigned declare that the project material, which I now submit, is my own work. Any assistance received by way of borrowing from the work of others has been cited and acknowledged within the work. I make this declaration in the knowledge that a breach of the rules pertaining to project submission may carry serious consequences. I am aware that the project will not be accepted unless this form has been handed in along with the project. Signed:_____________________ 2 Table of Contents Introduction – Page:4 External Marketing Audit – Page: The Market – Page: 6-11 Competition – Page: 11 - 14 Internal Marketing Audit – Page: 14 Strategic Issues Analysis – Page: 14 - 21 SWOT Analysis – Page: 21-24 Marketing Objectives – Page: 24 -25 Marketing Mix Decisions – Page: 25 - 29 Organisation and Implementation – Page: 29 -31 Control – Page: 31 -32 Bibliography : 33- 34 4- 6 3 Introduction Through extensive External and Internal analysis, the formulation for the best fit strategy has been developed and refined to suit the resources, culture and infrastructure...
Words: 11768 - Pages: 48
...Foreign investment opportunities for X X is among top generic pharmaceutical companies in the Europe. X’s basic line of business is the production and sale of prescription pharmaceuticals, non-prescription products and animal health products. Products are sold in five different regions: Slovenia, Central Europe, South-East Europe, East Europe, West Europe and Overseas Markets. I have done analysis of lately published report and company long term strategy from annual report. I suggest for company has to invest into countries ensuring demand in the future and developing. As well it is important to evaluate possibility to expand further in terms of country development in size and going to other regions. X is mostly acting in Europe and I think that company has to search for investment opportunities inside Europe. Turkey is as important as the BRIC countries in terms of its vast potentials and I have selected Turkey as country to invest. X can use Turkey in three selected directions: 1. Market with huge potential at the moment and bigger in the future; 2. Production capacities; 3. A bridge for further development to other East countries. Bellow I will list reason to go for and few risks company has to take into account. Macroeconomics reasons: GDP growth. Turkey will have one of biggest GDP growth in short term and long term compared to Emerging Europe and CEE. Economy size. Currently Turkey is biggest in CEE in population, which leads to No. 16 by GDP (PPP) in...
Words: 1345 - Pages: 6
...PREMIER UNIVERSITY ASSIGNMENT ON Financial Statements Analysis: Quantitative and Qualities Analysis Submitted To: Ms. Nilufar Sultana Lecturer Faculty of Business Studies Premier University Submitted By: 1. Shahida Khanam (0714111839) 2. Indrani Das (0714111862) 3. Supriya Singha (0714111874) 4. Tumpa Barua (0714111873) 5. Musfika Hossain Nammie (0714111870) 8th Semester (Finance) Section- A Date of Submission: 15th January, 2012 Preface As an institute of third world country we learn only theoretical knowledge. But as a student of Business Administration we need more realistic knowledge. After gathering realistic knowledge from any educational institution every student has to face practical work, because, a student cannot be a well learner by bookish knowledge. If the theoretical knowledge is not supported by the realistic knowledge, the knowledge will remain incomplete. As a student of Business Administration we think realistic knowledge is must for developing career. This assignment gives us the opportunity to get more realistic knowledge. Acknowledgement We have the immense pleasure and satisfaction in presenting this assignment, which is termination of our work. The gains of this assignment depend on the contribution of few people...
Words: 6340 - Pages: 26
...IIM BANGALORE Final Report for Contemporary Concerns Study Project Repositioning Strategy for Indian Pharmaceutical Companies in Global Context Submitted to PROFESSOR MURALI PATIBANDLA (FACULTY,CORPORATE STRATEGY AND POLICY) Submitted By Ravela Madhurika- 1211132 Tanveer Mohd Ansari-1211151 Contents Introduction .................................................................................................................................................. 3 Global Pharma Industry ............................................................................................................................ 3 Major players of the world pharmaceutical industry ................................................................................... 5 Major Players ............................................................................................................................................ 6 Pfizer Inc................................................................................................................................................ 6 GlaxoSmithKline .................................................................................................................................... 6 Sanofi-Aventis ....................................................................................................................................... 6 Novartis ..............................................................................................................
Words: 7934 - Pages: 32
...Riordan Corporate Compliance Plan Riordan Manufacturing Riordan Manufacturing is a global plastics producer with an employee base of 550. The company has projected annual earnings at $46million and is owned by Riordan Industries. There are different segments of the company but the major customers are the automotive parts manufacturers, aircraft manufacturers, the Department of Defense, beverage makers, bottlers, and appliance manufacturers. The company has recently undergone some strategic changes in manufacturing and marketing. Some of those recent changes are beginning to effect employee retention numbers. Situation Analysis Riordan Manufacturing has many issues and opportunities laid before them. The company must identify the proper issues in order to make the right adjustments. For the company to prosper, they must first take care of their employees. Issue Identification There are a myriad of issues that exist for Riordan Manufacturing. The company has gone through some recent structural changes because of the ever changing industry. Riordan decided to switch from an individual sales model to a team-based sales model. The issue with the above is that the individuals are used to being compensated solely based on their own performance; now there is apprehension about compensation at the team rate. Another issue is just the pay itself. Some managers are concerned that employees may take proprietary information and share it with competitors after leaving the company. Higher...
Words: 11305 - Pages: 46
...| Pfizer Stock Report | | Fall 2013 Research Project | | Pfizer Stock Report | | Fall 2013 Research Project | Saint Joseph’s University Contents II. Introduction 2 III. Macroeconomic Review 3 IV. Stock Market Analysis 6 V. Industry Analysis 8 VI. Company Strategic Analysis 10 VII. Company Financial Analysis 12 VIII. Application of Valuation Methodologies 13 IX. Conclusion and Recommendations 15 X. Exhibits 16 A. Exhibit A 17 B. Exhibit A 17 XI. References 18 Introduction Pfizer, headquartered in New York, NY, is committed to applying science and global resources to improve the health and well-being of individuals of all stages of life. Ian Read, CEO, leads the company through innovation and solid long term performances on the NYSE. Pfizer is also on the London, Euronext and Swiss exchanges. They make every effort to provide everybody with access to affordable, top of the line, safe remedies and health related services to those in need. Some of Pfizer’s most famous products include, Lipitor, Lyrica, Diflucan, Zithromax, Viagra, and Celebrex. Pfizer is committed to providing sustainable solutions to the biggest health issues in the world by continuously reviewing and updating their products and services to reduce their environmental footprints. The company maintains the highest ethical standards in all that they do such as sales and marketing to research and development. Pfizer, along with all industry...
Words: 4411 - Pages: 18
...An Analysis on Ratio of Beximco Pharmaceuticals Limited Letter of Transmittal 7th April, 2013 To, Mahabuba Rahman Lecturer of Finance IBAIS University House # 21/A, Road # 16 (Old-27) Dhanmondi, Dhaka 1209 Dear Madam, Here is the recommendation report on Ratio Analysis of “BEXIMCO PHARMACEUTICALS LTD.” As you read the report, you will get some idea about the pharmaceuticals industry of Bangladesh through our concerned organization. This report contains all the necessary information about the BEXIMCO PHARMACEUTICALS LTD. as like the mission and vision, the brief about all the activities and their services they performed and some other issues as your recommendation. We collected all this necessary information by internet, book and the annual report. We, therefore, pray and hope that you will encourage our work by accepting this report and if you have any further queries about the report you can contact us. Sincerely, Accepted By On behalf of Mahabuba Rahman Executive summary Report Proper 1. Introduction:- 2.1. Origin of the Report: The report was originated in our “Introduction to Finance” course. This report is being assigned as a part of learning objective of the course FIN-217 (Introduction to Finance). It is assigned by our honorable faculty “Mahabuba Rahman”, since a report is required for this course. Our teacher assigned us for this report to test our ability of preparing a business report and to learn. 1.2. Objective: ...
Words: 5787 - Pages: 24
...Internship Report On Management Accounting Practice At Beximco Pharmaceuticals Ltd: A Review Of Costing Function ‘Management Accounting Practice At Beximco Pharmaceuticals Ltd: A Review Of Costing Function’ by Syeda Afrina Sarwar ID: 07304063 BRAC Business School BRAC University, Bangladesh August 2011 ‘Management Accounting Practice At Beximco Pharmaceuticals Ltd: A Review Of Costing Function’ Submitted By: Syeda Afrina Sarwar ID: 07304063 BRAC Business School Submitted To: ------------------------------------------------Ms. Rahnuma Ahmed Lecturer BRAC Business School BRAC University, Bangladesh August 2011 Letter of Transmittal August 10, 2011 Ms. Rahnuma Ahmed Lecturer BRAC BUSINESS SCHOOL BRAC University 66, Mohakhali Dhaka-1212 Subject: Submission of Internship Report Dear Madam, I am submitting an internship report titled for ‘Management Accounting Practice At Beximco Pharmaceuticals Ltd: A Review of Costing Function’ as a part of the requirement of the course. Your guideline has been followed in every aspect of preparing this report. I have really enjoyed working on this project and I hope that my work would meet the level of your expectation. Any query on this report is appreciated. Thank You. Sincerely, Syeda Afrina Sarwar ID:07304063 Acknowledgement It’s difficult for me to thank all of those marvelous people who have contributed something of them to this report. There are of course some very special people who cannot go...
Words: 15094 - Pages: 61
...Internship Report On Management Accounting Practice At Beximco Pharmaceuticals Ltd: A Review Of Costing Function ‘Management Accounting Practice At Beximco Pharmaceuticals Ltd: A Review Of Costing Function’ by Syeda Afrina Sarwar ID: 07304063 BRAC Business School BRAC University, Bangladesh August 2011 ‘Management Accounting Practice At Beximco Pharmaceuticals Ltd: A Review Of Costing Function’ Submitted By: Syeda Afrina Sarwar ID: 07304063 BRAC Business School Submitted To: ------------------------------------------------Ms. Rahnuma Ahmed Lecturer BRAC Business School BRAC University, Bangladesh August 2011 Letter of Transmittal August 10, 2011 Ms. Rahnuma Ahmed Lecturer BRAC BUSINESS SCHOOL BRAC University 66, Mohakhali Dhaka-1212 Subject: Submission of Internship Report Dear Madam, I am submitting an internship report titled for ‘Management Accounting Practice At Beximco Pharmaceuticals Ltd: A Review of Costing Function’ as a part of the requirement of the course. Your guideline has been followed in every aspect of preparing this report. I have really enjoyed working on this project and I hope that my work would meet the level of your expectation. Any query on this report is appreciated. Thank You. Sincerely, Syeda Afrina Sarwar ID:07304063 Acknowledgement It’s difficult for me to thank all of those marvelous people who have contributed something of them to this report. There are of course some very special people who cannot go...
Words: 15094 - Pages: 61
...CHAPTER-1 1.1 Abstract: As Bangladesh is a developing country, the corporate finance is growing very slightly in our country. One of the important aspects of a corporation is its "Dividend Policy" that affects the financial structure, flow of funds, liquidity, price of stocks, and shareholder's satisfaction. This paper attempts to determine how the Beximco Pharmaceuticals Ltd (BPL) uses its dividend policy to increase the value of the firm and the impact of dividend policy on its stock price. We tried to illustrate and analyze net income, earning per share, cash dividend, stock dividend, dividend payout ratio and right share for empirical analysis of dividend distribution of Beximco Pharmaceuticals Ltd (BPL).The expectations of dividends by shareholders helps them determine the share value, therefore, dividend policy is a significant decision taken by the financial managers of any company. 1.2 Introduction: Dividend Policy is concerned with taking a decision regarding paying cash in the present or paying an increased dividend at a later stage. The firm could also pay in the form of stock dividends which unlike cash dividends do not provide liquidity to the investor; however, it ensures capital gains to the stockholders. The expectations of dividends by shareholders helps them determine the share value, therefore, dividend policy is a significant decision taken by the financial managers of any company. . 1.3 An Overview of Beximco Pharmaceuticals Ltd (BPL): Beximco Pharmaceuticals...
Words: 4214 - Pages: 17
...Organization Overview or Profile of the Organization Beximco Pharmaceutical Ltd. is a leading edge pharmaceutical company based in Dhaka, Bangladesh and is a member of the Beximco Group. The history of pharmaceutical business of the company dates back to the early 70s, when it started to import market and distribute medicines from world renowned companies like Upjohn Inc. of USA and Bayer AG of Germany. Since the very beginning, the company was highly successful in generating increased demand for its products which eventually justified local production. It completed its registration in 1976 and started its operation in 1980 by manufacturing and marketing licensee products of Bayer AG of Germany and Upjohn Inc. of USA. After its initial years of struggle it broke ground with the launching of its own products in 1983. In 1985 BPL was listed in Dhaka Stock Exchange (DSE) as a Public Limited Company. The journey continued and barrier after barrier were crossed, challenges were faced and overcome to transform BPL into what it is at present. Now it has grown to become nation's one of the leading pharmaceutical companies, supplying more than 10% of the country's total medicine need. In the process, it was enlisted in Chittagong and London Stock Exchange. Today Beximco manufactures and markets its own `branded generics' for almost all diseases from AIDS to cancer, from infection to asthma, from hypertension to diabetes for both national and international markets ( Beximco Pharmaceutical...
Words: 4414 - Pages: 18
...Unethical Marketing of Prescription Drugs: Misleading Direct-To-Consumer Advertising and Disease Mongering. October 3, 2011 Unethical Marketing of Prescription Drugs Introduction The purpose of this ethical paper is to investigate the marketing tactics being used by pharmaceutical companies and discuss the ethical issues involved. The primary source of information discussed in this paper was gathered from analysis of business and scholar journals, case studies, and current news articles. The main focus of my research was placed on the unethical practices of pharmaceutical companies and the current marketing regulations in the United States. The unethical practices primarily covered in this paper include disease/fear mongering, and the misuse of direct-to-consumer & physician-directed marketing to increase the profits of pharmaceutical firms. But before we get into the unethical practices taking place in today’s pharmaceutical industry, let’s take a look at the idea of ethics. So, what exactly is ethics? Merriam-Webster defines ethics as “the discipline dealing with what is good and bad and with moral duty and obligation,” and “a theory or system of moral values” (Merriam-Webster, 2011). As you can see, this is a complex but vague definition to say the least. In today’s world of international business where firms operate across cultural boundaries and face stiff competition in the fight for profits, it’s even more difficult to clearly define the meaning of...
Words: 3386 - Pages: 14
